Chronic Neuregulin-1β Treatment Mitigates the Progression of Post-Myocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis and Key Oxidant-Producing Enzymes

Type 1 diabetes mellitus (DM) patients surviving myocardial infarction (MI) have substantially higher cardiovascular morbidity and mortality compared to their non-diabetic counterparts owing to the more frequent development of subsequent heart failure (HF). Neuregulin (NRG)-1β is released from cardi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Card Fail
Huvudupphovsmän: Gupte, Manisha, Lal, Hind, Ahmad, Firdos, Sawyer, Douglas B, Hill, Michael F
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716474/
https://ncbi.nlm.nih.gov/pubmed/28870731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2017.08.456
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk